Chinese General Practice ›› 2022, Vol. 25 ›› Issue (21): 2610-2617.DOI: 10.12114/j.issn.1007-9572.2022.0178
Special Issue: 内分泌代谢性疾病最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2022-01-03
Revised:
2022-04-24
Published:
2022-07-20
Online:
2022-03-04
Contact:
Yanfang WANG
About author:
通讯作者:
汪艳芳
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0178
组别 | 只数 | 体质量(g) | 体长(cm) | Lee's指数 | 白棕比 | 脂肪指数 |
---|---|---|---|---|---|---|
WT组 | 6 | 27.48±1.16 | 8.30±0.32 | 363.84±11.01 | 3.05±0.09 | 0.020 7±0.003 8 |
Mstn(+/-)组 | 6 | 29.26±1.55 | 8.58±0.15 | 359.19±10.80 | 2.24±0.12a | 0.017 7±0.004 1 |
Mstn(-/-)组 | 6 | 31.14±1.71a | 9.12±0.18ab | 345.07±12.80ab | 1.75±0.14ab | 0.014 9±0.001 5 |
WT+DM组 | 6 | 22.22±2.29a | 8.36±0.19 | 335.95±7.70a | 4.33±0.19a | 0.041 2±0.006 5a |
Mstn(+/-)+DM组 | 6 | 23.88±1.94 | 8.76±0.28 | 334.39±5.31 | 3.28±0.06d | 0.025 1±0.004 0d |
Mstn(-/-)+DM组 | 6 | 24.22±1.70d | 9.28±0.13d | 311.62±4.44de | 2.13±0.15de | 0.016 9±0.005 0d |
F值 | 19.510 | 16.621 | 21.199 | 259.435 | 24.230 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 1 Comparison of weight,body length,Lee index,white-brown fat ratio and fat mass index in six groups of mice
组别 | 只数 | 体质量(g) | 体长(cm) | Lee's指数 | 白棕比 | 脂肪指数 |
---|---|---|---|---|---|---|
WT组 | 6 | 27.48±1.16 | 8.30±0.32 | 363.84±11.01 | 3.05±0.09 | 0.020 7±0.003 8 |
Mstn(+/-)组 | 6 | 29.26±1.55 | 8.58±0.15 | 359.19±10.80 | 2.24±0.12a | 0.017 7±0.004 1 |
Mstn(-/-)组 | 6 | 31.14±1.71a | 9.12±0.18ab | 345.07±12.80ab | 1.75±0.14ab | 0.014 9±0.001 5 |
WT+DM组 | 6 | 22.22±2.29a | 8.36±0.19 | 335.95±7.70a | 4.33±0.19a | 0.041 2±0.006 5a |
Mstn(+/-)+DM组 | 6 | 23.88±1.94 | 8.76±0.28 | 334.39±5.31 | 3.28±0.06d | 0.025 1±0.004 0d |
Mstn(-/-)+DM组 | 6 | 24.22±1.70d | 9.28±0.13d | 311.62±4.44de | 2.13±0.15de | 0.016 9±0.005 0d |
F值 | 19.510 | 16.621 | 21.199 | 259.435 | 24.230 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 只数 | TG | TC | LDL-C | HDL-C | FFA |
---|---|---|---|---|---|---|
WT组 | 6 | 1.17±0.06 | 2.84±0.23 | 0.36±0.02 | 0.66±0.04 | 0.62±0.01 |
Mstn(+/-)组 | 6 | 1.11±0.03 | 2.45±0.21a | 0.37±0.02 | 0.67±0.03 | 0.62±0.01 |
Mstn(-/-)组 | 6 | 1.02±0.06ab | 2.51±0.05a | 0.43±0.13 | 0.67±0.01 | 0.61±0.01 |
WT+DM组 | 6 | 1.62±0.06a | 5.13±0.20a | 0.50±0.03a | 0.38±0.01a | 0.78±0.02a |
Mstn(+/-)+DM组 | 6 | 1.44±0.04d | 4.27±0.18d | 0.49±0.02 | 0.44±0.02d | 0.72±0.01d |
Mstn(-/-)+DM组 | 6 | 1.38±0.02d | 3.81±0.18de | 0.43±0.02d | 0.50±0.01de | 0.70±0.01d |
F值 | 112.663 | 174.600 | 31.258 | 458.253 | 110.621 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 2 Comparison of levels of serum TG,TC,LDL-C,HDL-C and FFA of in six groups of mice
组别 | 只数 | TG | TC | LDL-C | HDL-C | FFA |
---|---|---|---|---|---|---|
WT组 | 6 | 1.17±0.06 | 2.84±0.23 | 0.36±0.02 | 0.66±0.04 | 0.62±0.01 |
Mstn(+/-)组 | 6 | 1.11±0.03 | 2.45±0.21a | 0.37±0.02 | 0.67±0.03 | 0.62±0.01 |
Mstn(-/-)组 | 6 | 1.02±0.06ab | 2.51±0.05a | 0.43±0.13 | 0.67±0.01 | 0.61±0.01 |
WT+DM组 | 6 | 1.62±0.06a | 5.13±0.20a | 0.50±0.03a | 0.38±0.01a | 0.78±0.02a |
Mstn(+/-)+DM组 | 6 | 1.44±0.04d | 4.27±0.18d | 0.49±0.02 | 0.44±0.02d | 0.72±0.01d |
Mstn(-/-)+DM组 | 6 | 1.38±0.02d | 3.81±0.18de | 0.43±0.02d | 0.50±0.01de | 0.70±0.01d |
F值 | 112.663 | 174.600 | 31.258 | 458.253 | 110.621 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 只数 | PPAR-γ | PGC-1α | UCP1 | CD137 |
---|---|---|---|---|---|
WT组 | 6 | 0.879±0.016 | 0.705±0.012 | 0.236±0.020 | 0.081±0.002 |
Mstn(+/-)组 | 6 | 0.908±0.112 | 0.711±0.023 | 0.767±0.069a | 0.111±0.004a |
Mstn(-/-)组 | 6 | 1.108±0.026ab | 0.926±0.076ab | 0.800±0.049a | 0.129±0.003ab |
WT+DM组 | 6 | 0.170±0.005a | 0.189±0.012a | 0.073±0.001a | 0.025±0.002a |
Mstn(+/-)+DM组 | 6 | 0.190±0.010 | 0.173±0.010 | 0.095±0.010 | 0.060±0.002d |
Mstn(-/-)+DM组 | 6 | 0.348±0.009de | 0.311±0.008de | 0.165±0.008de | 0.104±0.008de |
F值 | 446.360 | 539.281 | 528.637 | 538.335 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 3 Comparison of relative expression levels of PPARγ,PGC-1α,UCP1 and CD137 protein in white fat of six groups of mice
组别 | 只数 | PPAR-γ | PGC-1α | UCP1 | CD137 |
---|---|---|---|---|---|
WT组 | 6 | 0.879±0.016 | 0.705±0.012 | 0.236±0.020 | 0.081±0.002 |
Mstn(+/-)组 | 6 | 0.908±0.112 | 0.711±0.023 | 0.767±0.069a | 0.111±0.004a |
Mstn(-/-)组 | 6 | 1.108±0.026ab | 0.926±0.076ab | 0.800±0.049a | 0.129±0.003ab |
WT+DM组 | 6 | 0.170±0.005a | 0.189±0.012a | 0.073±0.001a | 0.025±0.002a |
Mstn(+/-)+DM组 | 6 | 0.190±0.010 | 0.173±0.010 | 0.095±0.010 | 0.060±0.002d |
Mstn(-/-)+DM组 | 6 | 0.348±0.009de | 0.311±0.008de | 0.165±0.008de | 0.104±0.008de |
F值 | 446.360 | 539.281 | 528.637 | 538.335 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 只数 | PPAR-γ | PGC-1α | UCP1 | CD137 |
---|---|---|---|---|---|
WT组 | 6 | 1.359±0.060 | 0.929±0.008 | 0.658±0.038 | 0.079±0.002 |
Mstn(+/-)组 | 6 | 1.920±0.050a | 1.111±0.050a | 0.809±0.017a | 0.152±0.009a |
Mstn(-/-)组 | 6 | 2.052±0.040ab | 1.556±0.059ab | 0.830±0.030a | 0.273±0.016ab |
WT+DM组 | 6 | 0.301±0.014a | 0.187±0.011a | 0.092±0.007a | 0.062±0.003a |
Mstn(+/-)+DM组 | 6 | 0.455±0.027d | 0.251±0.020d | 0.129±0.006d | 0.130±0.006d |
Mstn(-/-)+DM组 | 6 | 1.218±0.085de | 0.645±0.014de | 0.288±0.010de | 0.168±0.004de |
F值 | 1 196.913 | 1 463.654 | 1 493.055 | 490.418 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 4 Comparison of relative expression levels of PPAR-γ,PGC-1α,UCP1 and CD137 protein in brown fat of six groups of mice
组别 | 只数 | PPAR-γ | PGC-1α | UCP1 | CD137 |
---|---|---|---|---|---|
WT组 | 6 | 1.359±0.060 | 0.929±0.008 | 0.658±0.038 | 0.079±0.002 |
Mstn(+/-)组 | 6 | 1.920±0.050a | 1.111±0.050a | 0.809±0.017a | 0.152±0.009a |
Mstn(-/-)组 | 6 | 2.052±0.040ab | 1.556±0.059ab | 0.830±0.030a | 0.273±0.016ab |
WT+DM组 | 6 | 0.301±0.014a | 0.187±0.011a | 0.092±0.007a | 0.062±0.003a |
Mstn(+/-)+DM组 | 6 | 0.455±0.027d | 0.251±0.020d | 0.129±0.006d | 0.130±0.006d |
Mstn(-/-)+DM组 | 6 | 1.218±0.085de | 0.645±0.014de | 0.288±0.010de | 0.168±0.004de |
F值 | 1 196.913 | 1 463.654 | 1 493.055 | 490.418 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[1] | CHEN Yijing, XU Qi, LIU Zhongdian, QIN Lingqiao, CHEN Shuping, TANG Weiting, ZHONG Qiuan. The Regulatory Role of Hexosamine Biosynthesis Pathway in Vascular Endothelial Inflammation [J]. Chinese General Practice, 2025, 28(15): 1871-1877. |
[2] | TIAN Ke, LENG Qiufeng, LYU Jing, MIAO Guoying, WANG Xinhui, XIE Hui, LIU Qu, YAO Chunxia. Bidirectional Regulation of Keratinocyte Proliferation and Apoptosis by Metformin via NLRP3 Inflammasome Pathway [J]. Chinese General Practice, 2025, 28(06): 742-750. |
[3] | YANG Can, LI Ning, LI Xuefei, ZHAO Li, XU Hao, SHI Qi, WANG Yongjun, LIANG Qianqian. Efficacy of Zang Bi Formula in Treating Arthritis and Its Pulmonary Complications in Rheumatoid Arthritis Interstitial Lung Disease Mice [J]. Chinese General Practice, 2024, 27(24): 3015-3022. |
[4] | QIN Fang, MA Tiantian, YU Zifu, LIU Xihua. Study on Mechanism of Myocardial Fibrosis in ApoE-/- Atherosclerotic Mice Inhibited by Aerobic Exercise [J]. Chinese General Practice, 2024, 27(05): 557-562. |
[5] | Keng CHEN, Yiyao DENG, Shunlai SHANG, Qinggang LI, Xiangmei CHEN. Chinese Herbal Formula Shenyi Improves Kidney Injury and Inhibits the Activation of the Alternative Complement Pathway in a Mouse Model of Lupus Nephritis [J]. Chinese General Practice, 2022, 25(26): 3298-3307. |
[6] |
ZHANG Yushuang, YU Fuyang, WU Zhongbing, WANG Yiran, LI Jing.
Analysis of Gut Flora in a Mouse Model of Esophageal Squamous Cell Carcinoma in Situ [J]. Chinese General Practice, 2022, 25(08): 945-951. |
[7] | CHEN Shaohua,WANG Chinyun,WU Changgui,ZHAO Xiao,XU Hao,SHI Qi,LIANG Qianqian. Efficacy and Mechanism of Action of Danggui Niantong Decoction against Acute Gouty Arthritis in a Mouse Model:an Experimental Study [J]. Chinese General Practice, 2021, 24(24): 3116-3121. |
[8] | YU Lei,YANG Yunshuang,LI Yanhui,LIU Xiaochen,DU Lei,WANG Sinian,ZHANG Rong. Protective Effect of Bushen Jiedu Prescription on Radiation-induced Thymus Injury in Mice [J]. Chinese General Practice, 2020, 23(9): 1164-1168. |
[9] | CHANG Quan,ZHANG Nana,MA Dong. Bioinformatics Analysis of Myelin KLF5 Deficiency Inhibiting Abdominal Aortic Aneurysm Formation in Mice [J]. Chinese General Practice, 2020, 23(6): 692-698. |
[10] | ZHANG Yan*,FAN Xiaoxiang,ZHANG Meiwu,ZHUANG Luhui,MAO Dafeng. Role of NLRC5 in the Activation of Hepatic Stellate Cells Induced by TGF-β1 and Reversal of Hepatic Fibrosis [J]. Chinese General Practice, 2020, 23(24): 3051-3059. |
[11] | LI Hongtao,LIN Yusen,ZOU Xiaoling,LI Wenjuan,MENG Ping,ZHANG Tiantuo. Effects of CpG Oligodeoxynucleotides on Airway Remodeling in Combined Allergic Rhinitis and Asthma Syndrome [J]. Chinese General Practice, 2019, 22(26): 3191-3197. |
[12] | ZHANG Na1LIU Xuefang,JIANG Shihong,WANG Qi,TIAN Yange. Yifeizhuji Decoction Combined with Cyclophosphamide for Reducing the Tumor Volume and Improving the Immunologic Functions in the Lewis Lung Carcinoma Mouse Model [J]. Chinese General Practice, 2018, 21(30): 3753-3756. |
[13] | XU Li,GE Qiongxiang,LIN Guoqiang. Effect of Mild Moxibustion on TRPV1 Expression in the Dorsal Root Ganglion in a Mouse Model of Pruritus Ani [J]. Chinese General Practice, 2018, 21(30): 3749-3752. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||